Cargando…

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

Detalles Bibliográficos
Autores principales:	Ungefroren, Hendrik, Konukiewitz, Björn, Braun, Rüdiger, Wellner, Ulrich Friedrich, Keck, Tobias, Marquardt, Jens-Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913373/ https://www.ncbi.nlm.nih.gov/pubmed/36765537 http://dx.doi.org/10.3390/cancers15030581

Ejemplares similares

TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation
por: Ungefroren, Hendrik, et al.
Publicado: (2023)

Suppressive Role of ACVR1/ALK2 in Basal and TGFβ1-Induced Cell Migration in Pancreatic Ductal Adenocarcinoma Cells and Identification of a Self-Perpetuating Autoregulatory Loop Involving the Small GTPase RAC1b
por: Ungefroren, Hendrik, et al.
Publicado: (2022)

A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
por: Schmidtlein, Paula M., et al.
Publicado: (2021)

Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
por: Schmidtlein, Paula Marie, et al.
Publicado: (2021)

The Quasimesenchymal Pancreatic Ductal Epithelial Cell Line PANC-1—A Useful Model to Study Clonal Heterogeneity and EMT Subtype Shifting
por: Ungefroren, Hendrik, et al.
Publicado: (2022)

Smad4 (DPC4)--a potent tumour suppressor?
por: Duff, E. K., et al.
Publicado: (1998)

Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response
por: Braun, Rüdiger, et al.
Publicado: (2023)

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses
por: Ungefroren, Hendrik, et al.
Publicado: (2022)

The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling
por: Ungefroren, Hendrik, et al.
Publicado: (2020)

RAC1B Regulation of TGFB1 Reveals an Unexpected Role of Autocrine TGFβ1 in the Suppression of Cell Motility
por: Ungefroren, Hendrik, et al.
Publicado: (2020)

Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-β signaling
por: Demagny, Hadrien, et al.
Publicado: (2015)

The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study
por: Shin, Sang Hyun, et al.
Publicado: (2017)

Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling
por: Ungefroren, Hendrik, et al.
Publicado: (2022)

Autocrine TGFβ1 Opposes Exogenous TGFβ1-Induced Cell Migration and Growth Arrest through Sustainment of a Feed-Forward Loop Involving MEK-ERK Signaling
por: Ungefroren, Hendrik, et al.
Publicado: (2021)

Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3ε
por: Liffers, Sven-T, et al.
Publicado: (2011)

DPC4 Expression in the Small Intestinal Adenocarcinomas
por: Lee, Sun Jae, et al.
Publicado: (2012)

Analysis of the DPC4 Gene in Gastric Carcinoma
por: Nishizuka, Satoshi, et al.
Publicado: (1997)

RAC1B Induces SMAD7 via USP26 to Suppress TGFβ1-Dependent Cell Migration in Mesenchymal-Subtype Carcinoma Cells
por: Ungefroren, Hendrik, et al.
Publicado: (2020)

Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling
por: Demagny, Hadrien, et al.
Publicado: (2015)

Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1
por: Ungefroren, Hendrik, et al.
Publicado: (2011)

Expression and significance of transforming growth factor-β receptor type II and DPC4/Smad4 in non-small cell lung cancer
por: CHEN, HONG, et al.
Publicado: (2015)

The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
por: Racu, Marie-Lucie, et al.
Publicado: (2022)

The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer
por: Xu, Jin-Zhi, et al.
Publicado: (2019)

Preclinical Patient-Derived Culture Models for Personalized Treatment of Pancreatic Cancer: A Dream of the Future or Useful Practice?
por: Braun, Rüdiger, et al.
Publicado: (2023)

Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling
por: Ungefroren, Hendrik, et al.
Publicado: (2013)

SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
por: Dardare, Julie, et al.
Publicado: (2020)

Integrating DPC++/oneAPI in the ATLAS software
por: Krasznahorkay, Attila
Publicado: (2023)

Expression pattern of p-Smad2/Smad4 as a predictor of survival in invasive breast ductal carcinoma
por: Liu, Nannan, et al.
Publicado: (2020)

SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
por: Chen, Yu-Wen, et al.
Publicado: (2014)

Negative Control of Cell Migration by Rac1b in Highly Metastatic Pancreatic Cancer Cells Is Mediated by Sequential Induction of Nonactivated Smad3 and Biglycan
por: Otterbein, Hannah, et al.
Publicado: (2019)

The Effect of Hypoxia on the Stemness and Differentiation Capacity of PDLC and DPC
por: Zhou, Yinghong, et al.
Publicado: (2014)

A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
por: Singh, Puneet, et al.
Publicado: (2011)

Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
por: Färber, Benedikt, et al.
Publicado: (2023)

Kidney Transplantation after Extended Multivisceral Resection for Pancreatic Ductal Adenocarcinoma
por: Lapshyn, Hryhoriy, et al.
Publicado: (2018)

Elucidating the Synergistic Role of Elm1 and Gin4 Kinases in Regulating Septin Hourglass Assembly
por: Marquardt, Joseph, et al.
Publicado: (2023)

Genome Sequence of the Heteropolysaccharide-Producing Strain Lactobacillus mucosae DPC 6426
por: Ryan, Paul M., et al.
Publicado: (2015)

Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbe
por: Ryan, Paul M., et al.
Publicado: (2019)

DPC29 promotes post-initiation mitochondrial translation in Saccharomyces cerevisiae
por: Hubble, Kyle A, et al.
Publicado: (2023)

SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium
por: Kang, Ya'an, et al.
Publicado: (2014)

Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis
por: Wang, Jin-Dao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qnmr62te37mp6vnlltjfbet3av